Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 78.60
-0.80 (-1.01%)
Aug 28, 2026, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 13.16 billion as of August 28, 2026. Its market cap has decreased by -59.51% in one year.
Market Cap
13.16B
Enterprise Value
12.54B
Revenue
34.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
78.60
ChartMarket Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 13.16B, an increase of 206.51%. That is a compound annual growth rate of 10.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 13.16B | -59.82% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 20.74B |
| TaiMed Biologics | 18.61B |
| Ever Supreme Bio Technology | 16.42B |
| Gongwin Biopharm Holdings | 15.58B |
| EirGenix | 15.20B |
| ACRO Biomedical | 14.99B |
| TCM Biotech International | 10.40B |
| AP Biosciences | 9.84B |